Lung Cancers Not Yet Recruiting Phase 1 Trials for Osimertinib (DB09330)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03891615Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung CancerTreatment